These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35190547)

  • 1. Disentangling the recognition complexity of a protein hub using a nanopore.
    Mayse LA; Imran A; Larimi MG; Cosgrove MS; Wolfe AJ; Movileanu L
    Nat Commun; 2022 Feb; 13(1):978. PubMed ID: 35190547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.
    Imran A; Moyer BS; Canning AJ; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
    Biochem J; 2021 Jun; 478(11):2145-2161. PubMed ID: 34032265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
    Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
    J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site.
    Imran A; Moyer BS; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
    ACS Chem Biol; 2022 Jun; 17(6):1586-1597. PubMed ID: 35613319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
    Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
    J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
    Shinsky SA; Cosgrove MS
    J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.
    Patel A; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32158-61. PubMed ID: 18829459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex.
    Patel A; Vought VE; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32162-75. PubMed ID: 18829457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition of histone H3 by the WD40 protein WDR5.
    Couture JF; Collazo E; Trievel RC
    Nat Struct Mol Biol; 2006 Aug; 13(8):698-703. PubMed ID: 16829960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode.
    Yang Y; Xu L; Zhang S; Yao L; Ding Y; Li W; Chen X
    J Biol Chem; 2024 Jul; 300(7):107468. PubMed ID: 38876301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.
    Song JJ; Kingston RE
    J Biol Chem; 2008 Dec; 283(50):35258-64. PubMed ID: 18840606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models.
    Teuscher KB; Chowdhury S; Meyers KM; Tian J; Sai J; Van Meveren M; South TM; Sensintaffar JL; Rietz TA; Goswami S; Wang J; Grieb BC; Lorey SL; Howard GC; Liu Q; Moore WJ; Stott GM; Tansey WP; Lee T; Fesik SW
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2211297120. PubMed ID: 36574664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5.
    Ahmad M; Imran A; Movileanu L
    Int J Biol Macromol; 2024 Feb; 258(Pt 2):128969. PubMed ID: 38158065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction.
    Ye X; Chen G; Jin J; Zhang B; Wang Y; Cai Z; Ye F
    Curr Med Chem; 2020; 27(33):5530-5542. PubMed ID: 31132972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
    Ye X; Zhang R; Lian F; Zhang W; Lu W; Han J; Zhang N; Jin J; Luo C; Chen K; Ye F; Ding H
    Bioorg Med Chem Lett; 2019 Feb; 29(4):638-645. PubMed ID: 30626558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif.
    Huang X; Zhang C; Shang X; Chen Y; Xiao Q; Wei Z; Wang G; Zhen X; Xu G; Min J; Shen S; Liu Y
    Cell Death Dis; 2024 May; 15(5):335. PubMed ID: 38744853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5.
    Senisterra G; Wu H; Allali-Hassani A; Wasney GA; Barsyte-Lovejoy D; Dombrovski L; Dong A; Nguyen KT; Smil D; Bolshan Y; Hajian T; He H; Seitova A; Chau I; Li F; Poda G; Couture JF; Brown PJ; Al-Awar R; Schapira M; Arrowsmith CH; Vedadi M
    Biochem J; 2013 Jan; 449(1):151-9. PubMed ID: 22989411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAQR3 modulates H3K4 trimethylation by spatial modulation of the regulatory subunits of COMPASS-like complexes in mammalian cells.
    Liu C; Zhang Y; Hou Y; Shen L; Li Y; Guo W; Xu D; Liu G; Zhao Z; Man K; Pan Y; Wang Z; Chen Y
    Biochem J; 2015 May; 467(3):415-24. PubMed ID: 25706881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Potent 2-Aryl-6,7-dihydro-5 H-pyrrolo[1,2- a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design.
    Wang F; Jeon KO; Salovich JM; Macdonald JD; Alvarado J; Gogliotti RD; Phan J; Olejniczak ET; Sun Q; Wang S; Camper D; Yuh JP; Shaw JG; Sai J; Rossanese OW; Tansey WP; Stauffer SR; Fesik SW
    J Med Chem; 2018 Jul; 61(13):5623-5642. PubMed ID: 29889518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction.
    Ding J; Liu L; Chiang YL; Zhao M; Liu H; Yang F; Shen L; Lin Y; Deng H; Gao J; Sage DR; West L; Llamas LA; Hao X; Kawatkar S; Li E; Jain RK; Tallarico JA; Canham SM; Wang H
    J Med Chem; 2023 Jun; 66(12):8310-8323. PubMed ID: 37307526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.